Sturgeon Patrick A

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$6,325.38
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Sturgeon Patrick A

According to the SEC Form 4 filings, Sturgeon Patrick A, being in a position of

  1. director at Carmell Therapeutics Corporation,
    оver the last 12 months, has bought 9737 shares for $5,183, and sold 0 shares,
    over all time since 2023-12-15, has bought 11324 shares for $6,325, and sold 0 shares.

The largest purchase of all time was on 2024-08-23 and amounted to 1587 shares of Carmell Therapeutics Corporation for $1,143.

Biography of Sturgeon Patrick A

No biography is available at this moment.

2024-09-06PurchaseCarmell Therapeutics Corporation
CTCX
director
1,261
0.0102%
$0.51$643-27.37%
2024-08-30PurchaseCarmell Therapeutics Corporation
CTCX
director
109
0.001%
$0.57$62-45.81%
2024-08-29PurchaseCarmell Therapeutics Corporation
CTCX
director
652
0.0058%
$0.56$365-36.97%
2024-08-28PurchaseCarmell Therapeutics Corporation
CTCX
director
970
0.0086%
$0.56$543-35.88%
2024-08-27PurchaseCarmell Therapeutics Corporation
CTCX
director
1,587
0.0178%
$0.71$1,127-46.69%
2024-08-26PurchaseCarmell Therapeutics Corporation
CTCX
director
1,587
0.0181%
$0.72$1,143-50.59%
2024-08-23PurchaseCarmell Therapeutics Corporation
CTCX
director
1,587
0.0181%
$0.72$1,143-51.17%
2024-08-21PurchaseCarmell Therapeutics Corporation
CTCX
director
1,984
0.0025%
$0.08$157-50%
2023-12-15PurchaseCarmell Therapeutics Corporation
CTCX
director
1,587
0.0181%
$0.72$1,143-55%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.